T1	CHEM 15 25	melatonina
#1	AnnotatorNotes T1	C0025219; melatonin; Organic Chemical · Hormone · Pharmacologic Substance
T2	DISO 32 60	respuesta inflamatoria aguda
#2	AnnotatorNotes T2	C1817978; acute inflammatory response; Pathologic Function
T3	PROC 77 123	colangiopancreatografía retrógrada endoscópica
#3	AnnotatorNotes T3	C0008310; Endoscopic Retrograde Cholangiopancreatography; Diagnostic Procedure
T4	ANAT 454 469	pancreatobiliar
#4	AnnotatorNotes T4	C2951305; Pancreaticobiliary system; Body System
T5	PROC 212 258	colangiopancreatografía retrógrada endoscópica
#5	AnnotatorNotes T5	C0008310; Endoscopic Retrograde Cholangiopancreatography; Diagnostic Procedure
T6	PROC 260 264	CPRE
#6	AnnotatorNotes T6	C0008310; Endoscopic Retrograde Cholangiopancreatography; Diagnostic Procedure
T7	DISO 301 329	respuesta inflamatoria aguda
#7	AnnotatorNotes T7	C1817978; acute inflammatory response; Pathologic Function
T8	CHEM 334 344	melatonina
#8	AnnotatorNotes T8	C0025219; melatonin; Organic Chemical · Hormone · Pharmacologic Substance
T9	PROC 773 786	aleatorizaron
#9	AnnotatorNotes T9	C0034656; Randomization; Research Activity
T10	CHEM 572 582	melatonina
#10	AnnotatorNotes T10	C0025219; melatonin; Organic Chemical · Hormone · Pharmacologic Substance
T11	CHEM 630 638	lipídica
#11	AnnotatorNotes T11	C0023779; Lipids; Organic Chemical
T12	PROC 668 672	CPRE
#12	AnnotatorNotes T12	C0008310; Endoscopic Retrograde Cholangiopancreatography; Diagnostic Procedure
T13	PROC 692 706	ensayo clínico
#13	AnnotatorNotes T13	C0008976; Clinical Trials; Research Activity
T14	PROC 993 997	FCEV
#14	AnnotatorNotes T14	C2239222; Vascular Endothelial Growth Factor Measurement; Laboratory Procedure
T15	DISO 752 768	coledocolitiasis
#15	AnnotatorNotes T15	C0701818; Choledocholithiasis; Disease or Syndrome
T16	CHEM 800 810	melatonina
#16	AnnotatorNotes T16	C0025219; melatonin; Organic Chemical · Hormone · Pharmacologic Substance
T17	PROC 813 820	placebo
#17	AnnotatorNotes T17	C0032042; Placebos; Therapeutic or Preventive Procedure
T18	PROC 840 844	CPRE
#18	AnnotatorNotes T18	C0008310; Endoscopic Retrograde Cholangiopancreatography; Diagnostic Procedure
T19	ANAT 873 879	sérica
#19	AnnotatorNotes T19	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T20	PROC 847 914	Se midió la concentración sérica de factor de necrosis tumoral alfa
#20	AnnotatorNotes T20	C2209004; serum tumor necrosis factor-alpha; Laboratory Procedure
T21	PROC 916 924	FNT-alfa
#21	AnnotatorNotes T21	C2209004; serum tumor necrosis factor-alpha; Laboratory Procedure
T22	PROC 927 941	interleucina-6
#22	AnnotatorNotes T22	C0919829; Interleukin 6 Measurement; Laboratory Procedure
T23	PROC 943 947	IL-6
#23	AnnotatorNotes T23	C0919829; Interleukin 6 Measurement; Laboratory Procedure
T24	PROC 950 991	factor de crecimiento endotelial vascular
#24	AnnotatorNotes T24	C2239222; Vascular Endothelial Growth Factor Measurement; Laboratory Procedure
T25	CHEM 1013 1021	lipídica
#25	AnnotatorNotes T25	C0023779; Lipids; Organic Chemical
T26	PROC 1093 1106	procedimiento
#26	AnnotatorNotes T26	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T27	ANAT 1059 1067	hepático
#27	AnnotatorNotes T27	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T28	ANAT 1173 1180	séricas
#28	AnnotatorNotes T28	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T29	CHEM 1184 1192	FNT alfa
#29	AnnotatorNotes T29	C1456820; Tumor Necrosis Factor-alpha; Amino Acid, Peptide, or Protein · Immunologic Factor
T30	CHEM 1194 1204	melatonina
#30	AnnotatorNotes T30	C0025219; melatonin; Organic Chemical · Hormone · Pharmacologic Substance
T31	PROC 1229 1236	placebo
#31	AnnotatorNotes T31	C0032042; Placebos; Therapeutic or Preventive Procedure
T32	PROC 1262 1266	IL-6
#32	AnnotatorNotes T32	C0919829; Interleukin 6 Measurement; Laboratory Procedure
T33	CHEM 1268 1278	melatonina
#33	AnnotatorNotes T33	C0025219; melatonin; Organic Chemical · Hormone · Pharmacologic Substance
T34	PROC 1303 1310	placebo
#34	AnnotatorNotes T34	C0032042; Placebos; Therapeutic or Preventive Procedure
T35	CHEM 1343 1353	melatonina
#35	AnnotatorNotes T35	C0025219; melatonin; Organic Chemical · Hormone · Pharmacologic Substance
T36	PROC 1602 1639	niveles de aspartato aminotransferasa
#36	AnnotatorNotes T36	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
T37	PROC 1378 1385	placebo
#37	AnnotatorNotes T37	C0032042; Placebos; Therapeutic or Preventive Procedure
T38	PROC 1641 1665	alanina aminotransferasa
#38	AnnotatorNotes T38	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T39	CHEM 1427 1435	lipídica
#39	AnnotatorNotes T39	C0023779; Lipids; Organic Chemical
T40	CHEM 1437 1447	melatonina
#40	AnnotatorNotes T40	C0025219; melatonin; Organic Chemical · Hormone · Pharmacologic Substance
T41	PROC 1470 1477	placebo
#41	AnnotatorNotes T41	C0032042; Placebos; Therapeutic or Preventive Procedure
T42	PROC 1592 1596	CPRE
#42	AnnotatorNotes T42	C0008310; Endoscopic Retrograde Cholangiopancreatography; Diagnostic Procedure
T43	CHEM 1613 1639	aspartato aminotransferasa
#43	AnnotatorNotes T43	C0004002; Aspartate Transaminase; Amino Acid, Peptide, or Protein · Enzyme
T44	PROC 1668 1685	bilirrubina total
#44	AnnotatorNotes T44	C0201913; Bilirubin, total measurement; Laboratory Procedure
T45	CHEM 1738 1748	melatonina
#45	AnnotatorNotes T45	C0025219; melatonin; Organic Chemical · Hormone · Pharmacologic Substance
T46	CHEM 1782 1792	melatonina
#46	AnnotatorNotes T46	C0025219; melatonin; Organic Chemical · Hormone · Pharmacologic Substance
T47	CHEM 1833 1843	melatonina
#47	AnnotatorNotes T47	C0025219; melatonin; Organic Chemical · Hormone · Pharmacologic Substance
T48	PROC 1888 1892	CPRE
#48	AnnotatorNotes T48	C0008310; Endoscopic Retrograde Cholangiopancreatography; Diagnostic Procedure
T49	CHEM 1940 1949	citocinas
#49	AnnotatorNotes T49	C0079189; cytokine; Amino Acid, Peptide, or Protein · Immunologic Factor
T50	CHEM 1982 1990	lipídica
#50	AnnotatorNotes T50	C0023779; Lipids; Organic Chemical
T51	PROC 1157 1192	concentraciones séricas de FNT alfa
#51	AnnotatorNotes T51	C2209004; serum tumor necrosis factor-alpha; Laboratory Procedure
T52	PROC 1337 1341	FCEV
#52	AnnotatorNotes T52	C2239222; Vascular Endothelial Growth Factor Measurement; Laboratory Procedure
T53	PROC 128 193	ensayo clínico aleatorizado, doble ciego y controlado con placebo
#53	AnnotatorNotes T53	C0599724; placebo controlled study; Research Activity · Intellectual Product + C0013072; Double-Blind Method; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T54	PROC 1921 1949	concentraciones de citocinas
#54	AnnotatorNotes T54	C2699541; Cytokine Measurement; Laboratory Procedure
T55	DISO 444 469	patología pancreatobiliar
T56	PROC 536 568	administración periprocedimiento
T57	DISO 592 614	respuesta inflamatoria
#55	AnnotatorNotes T57	C1155266; Inflammatory Response; Pathologic Function
T58	CHEM 883 914	factor de necrosis tumoral alfa
#56	AnnotatorNotes T58	C1456820; Tumor Necrosis Factor-alpha; Amino Acid, Peptide, or Protein · Immunologic Factor
T59	ANAT 972 982	endotelial
#57	AnnotatorNotes T59	C0014257; Endothelium; Tissue
T60	ANAT 983 991	vascular
#58	AnnotatorNotes T60	C0005847; Blood Vessel; Body Part, Organ, or Organ Component | C1283786; Entire blood vessel; Body Part, Organ, or Organ Component
T61	PROC 1023 1030	amilasa
#59	AnnotatorNotes T61	C0201883; Amylase measurement; Laboratory Procedure
T62	PROC 1033 1067	pruebas de funcionamiento hepático
#60	AnnotatorNotes T62	C0023901; Liver Function Tests; Laboratory Procedure
T63	CHEM 1668 1679	bilirrubina
#61	AnnotatorNotes T63	C0005437; Bilirubin; Organic Chemical · Biologically Active Substance
T64	PROC 1764 1778	administración
#62	AnnotatorNotes T64	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T65	PHYS 367 408	efectos inmunomoduladores y antioxidantes
#63	AnnotatorNotes T65	C0678889; Immunoregulation; Organism Function + C3179302; Antioxidant Effect; Physiologic Function
T66	LIVB 723 732	pacientes
#64	AnnotatorNotes T66	C0030705; Patients; Patient or Disabled Group
T67	Spec_cue 737 743	riesgo
T68	Duration 1068 1072	24 h
T73	LIVB 1868 1877	pacientes
#65	AnnotatorNotes T73	C0030705; Patients; Patient or Disabled Group
T75	LIVB 1994 2001	humanos
#66	AnnotatorNotes T75	C0086418; Homo sapiens; Human
T77	PHYS 960 982	crecimiento endotelial
#67	AnnotatorNotes T77	C1523343; endothelial cell development; Cell Function
T78	Time 551 568	periprocedimiento
T79	PHYS 617 638	peroxidación lipídica
#68	AnnotatorNotes T79	C0023775; Lipid Peroxidation; Molecular Function
T80	Time 821 838	periprocedimiento
T76	PHYS 1000 1021	peroxidación lipídica
#69	AnnotatorNotes T76	C0023775; Lipid Peroxidation; Molecular Function
T69	PHYS 1414 1435	peroxidación lipídica
#70	AnnotatorNotes T69	C0023775; Lipid Peroxidation; Molecular Function
T70	Time 1500 1516	preprocedimiento
#71	AnnotatorNotes T70	C3272300; Pre-Procedure; Temporal Concept
T71	Time 1521 1537	posprocedimiento
#72	AnnotatorNotes T71	C3272301; Post-Procedure; Temporal Concept
T72	PHYS 1969 1990	peroxidación lipídica
#73	AnnotatorNotes T72	C0023775; Lipid Peroxidation; Molecular Function
A1	Assertion T15 Speculated
T74	Neg_cue 1121 1123	No
T81	CONC 1136 1146	diferencia
A2	Assertion T81 Negated
#74	AnnotatorNotes T81	C1705241; Delta (difference); Quantitative Concept
R1	Negation Arg1:T74 Arg2:T81	
T82	Spec_cue 1899 1908	no parece
T83	CONC 1909 1916	afectar
A3	Assertion T83 Speculated
R2	Speculation Arg1:T82 Arg2:T83	
T84	Quantifier_or_Qualifier 1950 1966	proinflamatorias
R3	Has_Quantifier_or_Qualifier Arg1:T49 Arg2:T84	
#75	AnnotatorNotes T83	C0521102; Interferes with; Functional Concept
R4	Causes Arg1:T3 Arg2:T2	
T85	Observation 1 8	Efectos
#76	AnnotatorNotes T85	C1518681; Outcome of Therapy; Finding (?)
R5	Causes Arg1:T1 Arg2:T85	
R7	Causes Arg1:T6 Arg2:T7	
R8	Causes Arg1:T5 Arg2:T7	
R9	Location_of Arg1:T4 Arg2:T55	
R10	Causes Arg1:T8 Arg2:T65	
R11	Overlap Arg1:T65 Arg2:T55	
R13	Used_for Arg1:T10 Arg2:T56	
R14	Causes Arg1:T10 Arg2:T57	
R15	Causes Arg1:T10 Arg2:T79	
R16	Causes Arg1:T12 Arg2:T79	
R17	Causes Arg1:T12 Arg2:T57	
R18	Experiences Arg1:T66 Arg2:T15	
R19	Speculation Arg1:T67 Arg2:T15	
R20	Before Arg1:T9 Arg2:T16	
R21	Before Arg1:T9 Arg2:T17	
R22	Overlap Arg1:T16 Arg2:T80	
R23	Overlap Arg1:T17 Arg2:T80	
R24	Before Arg1:T9 Arg2:T18	
R25	Experiences Arg1:T66 Arg2:T16	
R26	Experiences Arg1:T66 Arg2:T17	
R27	Experiences Arg1:T66 Arg2:T18	
R28	Location_of Arg1:T19 Arg2:T20	
R29	Location_of Arg1:T19 Arg2:T21	
R30	Location_of Arg1:T59 Arg2:T77	
R31	Overlap Arg1:T62 Arg2:T68	
R32	Location_of Arg1:T27 Arg2:T62	
R33	After Arg1:T62 Arg2:T26	
R34	Before Arg1:T62 Arg2:T26	
R35	After Arg1:T20 Arg2:T26	
R36	Before Arg1:T20 Arg2:T26	
R37	After Arg1:T21 Arg2:T26	
R38	Before Arg1:T21 Arg2:T26	
R39	After Arg1:T22 Arg2:T26	
R40	Before Arg1:T22 Arg2:T26	
R41	After Arg1:T23 Arg2:T26	
R42	Before Arg1:T23 Arg2:T26	
R43	After Arg1:T24 Arg2:T26	
R44	Before Arg1:T24 Arg2:T26	
R45	After Arg1:T14 Arg2:T26	
R46	Before Arg1:T14 Arg2:T26	
R47	After Arg1:T76 Arg2:T26	
R48	Before Arg1:T76 Arg2:T26	
R49	After Arg1:T61 Arg2:T26	
R50	Before Arg1:T61 Arg2:T26	
R51	Location_of Arg1:T28 Arg2:T51	
R52	After Arg1:T51 Arg2:T30	
R53	Before Arg1:T51 Arg2:T30	
R54	After Arg1:T51 Arg2:T31	
R55	Before Arg1:T51 Arg2:T31	
R56	After Arg1:T32 Arg2:T33	
R57	Before Arg1:T32 Arg2:T33	
R58	After Arg1:T32 Arg2:T34	
R59	Before Arg1:T32 Arg2:T34	
R60	After Arg1:T52 Arg2:T35	
R61	Before Arg1:T52 Arg2:T35	
R62	After Arg1:T52 Arg2:T37	
R63	Before Arg1:T52 Arg2:T37	
R64	After Arg1:T69 Arg2:T40	
R65	Before Arg1:T69 Arg2:T40	
R66	After Arg1:T69 Arg2:T41	
R67	Before Arg1:T69 Arg2:T41	
R68	Overlap Arg1:T51 Arg2:T70	
R69	Overlap Arg1:T51 Arg2:T71	
R70	Overlap Arg1:T32 Arg2:T70	
R71	Overlap Arg1:T32 Arg2:T71	
R72	Overlap Arg1:T52 Arg2:T70	
R73	Overlap Arg1:T52 Arg2:T71	
R74	Overlap Arg1:T69 Arg2:T70	
R75	Overlap Arg1:T69 Arg2:T71	
R76	Before Arg1:T42 Arg2:T36	
R77	Before Arg1:T42 Arg2:T38	
R78	Before Arg1:T42 Arg2:T87	
R79	Used_for Arg1:T46 Arg2:T64	
T86	Observation 1805 1813	tolerada
R80	Overlap Arg1:T64 Arg2:T86	
T87	Observation 1668 1698	bilirrubina total disminuyeron
#77	AnnotatorNotes T87	C3203646; Bilirubin total decreased; Finding
R81	Before Arg1:T45 Arg2:T87	
T88	Observation 1641 1665;1686 1698	alanina aminotransferasa disminuyeron
#78	AnnotatorNotes T88	C0855618; Alanine aminotransferase decreased; Finding
R82	Experiences Arg1:T73 Arg2:T47	
T89	Observation 1856 1864	tolerada
R83	Experiences Arg1:T73 Arg2:T89	
R84	Overlap Arg1:T47 Arg2:T89	
R85	Experiences Arg1:T73 Arg2:T48	
R86	Experiences Arg1:T73 Arg2:T54	
R87	Experiences Arg1:T75 Arg2:T72	
R88	Experiences Arg1:T73 Arg2:T72	
R89	Experiences Arg1:T75 Arg2:T54	
R90	Experiences Arg1:T75 Arg2:T48	
R91	Experiences Arg1:T75 Arg2:T47	
R92	Experiences Arg1:T75 Arg2:T89	
T90	Observation 1602 1639;1686 1698	niveles de aspartato aminotransferasa disminuyeron
T91	Observation 737 751	riesgo alto de
#79	AnnotatorNotes T91	C0332167; High risk of; Finding
R93	Experiences Arg1:T66 Arg2:T91	
R94	Before Arg1:T91 Arg2:T15	
#80	AnnotatorNotes T86	C5684674; patient tolerated procedure well; Finding
#81	AnnotatorNotes T89	C5684674; patient tolerated procedure well; Finding
R6	Overlap Arg1:T10 Arg2:T78	
R12	Overlap Arg1:T56 Arg2:T78	
R95	Before Arg1:T42 Arg2:T44	
A4	Experiencer T66 Patient
A5	Experiencer T73 Patient
A6	Experiencer T75 Patient
R96	Has_Result_or_Value Arg1:T36 Arg2:T90	
R97	Has_Result_or_Value Arg1:T38 Arg2:T88	
R98	Has_Result_or_Value Arg1:T44 Arg2:T87	
